Ugo Fiocco

Summary

Affiliation: University of Padova
Country: Italy

Publications

  1. doi request reprint JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis
    Ugo Fiocco
    Rheumatology Unit, Department of Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy
    Immunol Res 58:61-9. 2014
  2. doi request reprint Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers
    Ugo Fiocco
    Department of Medicine, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy
    Joint Bone Spine 80:165-70. 2013
  3. doi request reprint Synovial biomarkers in psoriatic arthritis
    Ugo Fiocco
    Department of Medicine, University of Padua, Padua, Italy
    J Rheumatol Suppl 89:61-4. 2012
  4. ncbi request reprint [IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy]
    U Fiocco
    Cattedra e UOC di Reumatologia, Universita di Padova, Italia
    Reumatismo 56:62-73. 2004
  5. doi request reprint Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis
    U Fiocco
    Unit of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
    Autoimmun Rev 9:780-4. 2010
  6. doi request reprint Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept
    Ugo Fiocco
    Rheumatology Unit, University of Padova, Via Giustiniani 2 35128 Padova, Italy
    Autoimmun Rev 8:76-82. 2008
  7. ncbi request reprint [Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee]
    U Fiocco
    Cattedra e U O C di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Universita di Padova, Italia
    Reumatismo 58:268-74. 2006
  8. pmc Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint
    Ugo Fiocco
    Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
    Arthritis Res Ther 12:R148. 2010
  9. ncbi request reprint [Differences in pharmacology of tumor necrosis factor (TNF) antagonists]
    U Fiocco
    Cattedra di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Universita degli Studi di Padova, Italia
    Reumatismo 57:8-16. 2005
  10. pmc Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept
    U Fiocco
    Division of Rheumatology, Department of Medical and Surgical Sciences, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    Ann Rheum Dis 64:899-905. 2005

Collaborators

Detail Information

Publications23

  1. doi request reprint JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis
    Ugo Fiocco
    Rheumatology Unit, Department of Medicine, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy
    Immunol Res 58:61-9. 2014
    ....
  2. doi request reprint Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers
    Ugo Fiocco
    Department of Medicine, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy
    Joint Bone Spine 80:165-70. 2013
    ....
  3. doi request reprint Synovial biomarkers in psoriatic arthritis
    Ugo Fiocco
    Department of Medicine, University of Padua, Padua, Italy
    J Rheumatol Suppl 89:61-4. 2012
    ..5 mg)...
  4. ncbi request reprint [IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy]
    U Fiocco
    Cattedra e UOC di Reumatologia, Universita di Padova, Italia
    Reumatismo 56:62-73. 2004
    ....
  5. doi request reprint Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis
    U Fiocco
    Unit of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
    Autoimmun Rev 9:780-4. 2010
    ..In the light of these observations, CSF1/CSF1R interaction probably represents a more sensible therapeutic target than TNF-alpha blockade in the diffuse form of pigmented villonodular synovitis...
  6. doi request reprint Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept
    Ugo Fiocco
    Rheumatology Unit, University of Padova, Via Giustiniani 2 35128 Padova, Italy
    Autoimmun Rev 8:76-82. 2008
    ..CTLA4-Ig shows the capacity, either ex vivo or in vivo, to interrupt at multiple steps the ongoing inflammatory and destructive process, and to concur in restoring the immunoregulatory balance in RA...
  7. ncbi request reprint [Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee]
    U Fiocco
    Cattedra e U O C di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Universita di Padova, Italia
    Reumatismo 58:268-74. 2006
    ..Marked improvement of knee disease activity over time and sustained functional recover was obtained. US-ST evaluation before treatment initiation and at the end of follow-up confirmed the regression of knee joint synovial proliferation...
  8. pmc Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint
    Ugo Fiocco
    Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
    Arthritis Res Ther 12:R148. 2010
    ....
  9. ncbi request reprint [Differences in pharmacology of tumor necrosis factor (TNF) antagonists]
    U Fiocco
    Cattedra di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Universita degli Studi di Padova, Italia
    Reumatismo 57:8-16. 2005
    ....
  10. pmc Rheumatoid and psoriatic knee synovitis: clinical, grey scale, and power Doppler ultrasound assessment of the response to etanercept
    U Fiocco
    Division of Rheumatology, Department of Medical and Surgical Sciences, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    Ann Rheum Dis 64:899-905. 2005
    ....
  11. doi request reprint Evaluation of finger joint synovial vascularity in patients with rheumatoid arthritis using contrast-enhanced ultrasound with water immersion and a stabilized probe
    Roberto Stramare
    Department of Medical Diagnostic Sciences and Special Therapies, University of Padua Medical School, Padua, Italy
    J Clin Ultrasound 40:147-54. 2012
    ..CONCLUSIONS.: CEUS with a fixed probe on finger joints immersed in water detected synovial vascularization in RA, producing results suitable for standardized software analysis and avoiding artifacts...
  12. doi request reprint Improved detection of synovial boundaries in ultrasound examination by using a cascade of active-contours
    Elisa Veronese
    Department of Information Engineering, University of Padova, Via Gradenigo 6 b, 35131 Padova, Italy
    Med Eng Phys 35:188-94. 2013
    ..4±0.5mm), that are a better performance than those obtained by the raters with respect to the consensus...
  13. ncbi request reprint Contrast medium in power Doppler ultrasound for assessment of synovial vascularity: comparison with arthroscopy
    Ugo Fiocco
    Division of Rheumatology, Department of Medical and Surgical Sciences, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    J Rheumatol 30:2170-6. 2003
    ....
  14. ncbi request reprint Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis
    Leonardo Punzi
    Rheumatology Unit, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Autoimmun Rev 6:524-8. 2007
    ..In this new fashion, the most stimulating hypotheses involving TNF are those regarding genetic predisposition, angiogenesis and osteoclastogenesis...
  15. ncbi request reprint Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glands
    Paolo Sfriso
    Department of Clinical and Experimental Medicine, Section of Rheumatology, Centro di Eccellenza per la Ricerca Biomedica, Padova, Italy
    J Immunol 176:2581-9. 2006
    ..They also support a critical role for CXCR3 in the pathogenesis of SS and identify its agonists as potential therapeutic targets...
  16. ncbi request reprint Evaluation of lymph node perfusion using continuous mode harmonic ultrasonography with a second-generation contrast agent
    Leopoldo Rubaltelli
    Department of Medical Diagnostic Sciences and Special Therapies, University of Padua, Padua, Italy
    J Ultrasound Med 23:829-36. 2004
    ....
  17. ncbi request reprint [Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis]
    C Botsios
    Cattedra e U O C Reumatologia, Università Azienda Ospedaliera di Padova, Italia
    Reumatismo 59:32-7. 2007
    ..We evaluated both the efficacy and safety of anakinra in daily routine rheumatoid arthritis clinical practice...
  18. ncbi request reprint [Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects]
    C Botsios
    Dipartimento Scienze Mediche e Chirurgiche, Universita degli Studi, Padova, Italia
    Reumatismo 55:224-35. 2003
    ..At this time, treating physicians must weigh carefully the benefits of biologics against their safety, particularly in patients at risk of infection...
  19. ncbi request reprint Vascular changes in psoriatic knee joint synovitis
    U Fiocco
    Department of Medical and Surgical Sciences, University of Padova, Italy
    J Rheumatol 28:2480-6. 2001
    ....
  20. doi request reprint Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients
    Luisa Costa
    Rheumatology Unit, Department of Clinical and Experimental Medicine, University Federico II, Via S Pansini 5, 80131, Naples, Italy
    Clin Rheumatol 33:273-6. 2014
    ..The data suggests that anti-TNF-α agents are effective and safe in PsA patients with concomitant HCV. We suggest that the use of anti-TNF-α agents, accompanied by close monitoring, could be a therapeutic option. ..
  21. pmc Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro
    Francesca Oliviero
    Rheumatology Unit, Department of Medicine, University of Padova Padova, Italy
    Front Pharmacol 4:51. 2013
    ....
  22. pmc Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison
    B Combe
    Service d Immuno Rhumatologie, Hopital Lapeyronie, Montpellier, France
    Ann Rheum Dis 65:1357-62. 2006
    ..To compare the efficacy and safety of etanercept and sulfasalazine, alone and in combination, in patients with active rheumatoid arthritis despite sulfasalazine treatment...
  23. ncbi request reprint [Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatment with infliximab]
    A Hoxha
    Cattedra e U O C di Reumatologia, Universita di Padova
    Reumatismo 58:121-6. 2006
    ..We evaluated the induction and clinical significance of ANA, anti-dsDNA and anti-ENA during infliximab therapy in patients with Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)...